HealthQuill
Merck & Co., Inc. has bought global rights for an experimental oral drug to treat heart diseases from China’s Jiangsu Hengrui Pharmaceuticals Co., Ltd. in a $2 billion deal.
Drugs Health Pharma

Merck signs $2b licensing deal with Jiangsu Hengrui for heart disease drug

HQ Team March 25, 2025: Merck & Co., Inc. has bought global rights for an experimental oral drug to treat heart diseases from.

Read More
A diet rich in plant-based foods during midlife, with a lower intake of ultra-processed and moderate animal-based foods can help you to reach the age of 70, free from chronic diseases, a Harvard study reveals.
Drugs Health Research

Plant-based foods may help you live without chronic diseases until 70

HQ Team March 25, 2025: A diet rich in plant-based foods during midlife, with a lower intake of ultra-processed and moderate animal-based foods.

Read More
Novo Nordisk has inked a $2 billion licensing pact with United Laboratories International for the development, manufacturing and commercialising of the Chinese company’s “triple G” weight-loss candidate.
Drugs Medical Pharma

Novo Nordisk in $2b deal with Chinese firm for ‘triple-G’ obesity drug

HQ Team February 25, 2025: Novo Nordisk has inked a $2 billion licensing pact with United Laboratories International for the development, manufacturing and.

Read More
Progress in slowing child mortality and stillbirth deaths has received a severe blow due to funding cuts and shortages, with 1.9 million children dying in 2023 on account of stillbirths.
Drugs Health Pharma

Funding cuts ‘severely’ bleeding UN’s child survival, stillbirth programs

HQ Team March 25, 2025: Progress in slowing child mortality and stillbirth deaths has received a severe blow due to global funding cuts.

Read More
Obesity is a health risk that needs to be tackled worldwide
Health Medical

Weight loss offers health benefits, even if pounds creep back: Study

Bharti Jayshankar March 24, 2025: University of Gothenburg researchers have uncovered a silver lining for those who struggle to maintain weight loss. According.

Read More
Nova Nordisk's Ozempic has changed he weight loss landscape
Drugs Pharma

Brazil’s pharma giant Hypera to launch generic Ozempic in 2026

Bharti Jayshankar March 24, 2025: Brazilian pharmaceutical giant Hypera announced plans to introduce a generic version of semaglutide—the active ingredient in Novo Nordisk’s.

Read More
depression
Health Research

Research exposes dangers of viral claims in TikTok’s ADHD postings

HQ Team March 22, 2025: Social media misinformation, especially regarding mental health issues, is a rising problem. Platforms like YouTube and TikTok attract.

Read More
Being popular means being louder. An actor, musician, sportsperson or politician opening up about his or her mental health is better heard than an ordinary individual.
Opinion

Lone wolf fallacy: How sigma masculinity became internet’s toxic inside joke

Aparna S March 21, 2025: There was a time when online debates about masculinity revolved entirely around “alpha” versus “beta” males. Alphas were.

Read More
AstraZeneca’s drug for treating limited-stage small cell lung cancer got a recommendation for approval from an EU regulator panel, according to the British-Swedish drugmaker.
Pharma

AstraZeneca to invest $2.5 Billion in Beijing R&D hub, expands China presence

HQ Team March 21, 2025: AstraZeneca has announced a $2.5 billion investment in a new Beijing R&D center, partnerships with Harbour BioMed and.

Read More
US adults who will develop dementia every year will rise to one million in 2060 from 514,000 in 2020, according to a study published in Nature Medicine.
Health

Semaglutide may combat Alzheimer’s by reducing brain inflammation:Study

HQ Team March 21, 2025: A study from China adds to mounting evidence that semaglutide—a medication widely used for type 2 diabetes (Ozempic).

Read More